LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 6.94 | 771.67 | 1015 | 1045 | 0.9712 | 0.8707 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 6.94 | 771.67 | 969 | 1045 | 0.9272 | 0.6826 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 9.16 | 771.67 | 1059 | 1138 | 0.9302 | 0.7579 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 9.16 | 771.67 | 1049 | 1138 | 0.9214 | 0.7285 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 11.56 | 771.67 | 1158 | 1280 | 0.9043 | 0.7427 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 11.56 | 771.67 | 1115 | 1280 | 0.8707 | 0.6547 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 13.78 | 771.67 | 1252 | 1459 | 0.8577 | 0.6925 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 13.78 | 771.67 | 1196 | 1459 | 0.8193 | 0.6104 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.00 | 771.67 | 1279 | 1585 | 0.8067 | 0.6264 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.00 | 771.67 | 1277 | 1585 | 0.8054 | 0.6240 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.22 | 771.67 | 1283 | 1741 | 0.7368 | 0.5419 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.22 | 771.67 | 1305 | 1741 | 0.7494 | 0.5643 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.44 | 771.67 | 1316 | 1910 | 0.6887 | 0.5039 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.44 | 771.67 | 1308 | 1910 | 0.6845 | 0.4969 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 22.66 | 771.67 | 1315 | 2141 | 0.6141 | 0.4362 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 22.66 | 771.67 | 1325 | 2141 | 0.6187 | 0.4436 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.89 | 771.67 | 1326 | 2397 | 0.5530 | 0.3923 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.89 | 771.67 | 1361 | 2397 | 0.5676 | 0.4147 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 27.11 | 771.67 | 1346 | 2675 | 0.5032 | 0.3637 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 27.11 | 771.67 | 1349 | 2675 | 0.5043 | 0.3654 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.33 | 771.67 | 1373 | 2939 | 0.4671 | 0.3480 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.33 | 771.67 | 1381 | 2939 | 0.4698 | 0.3521 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 31.55 | 771.67 | 1404 | 3196 | 0.4392 | 0.3390 | MN20160304_L01 | C21 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 31.55 | 771.67 | 1394 | 3196 | 0.4361 | 0.3343 | MN20160304_L01 | N12 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 33.78 | 771.67 | 1414 | 3499 | 0.4040 | 0.3200 | MN20160304_L01 | C21 |